Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy.
In conclusion, a novel cytotoxic drug-loaded nanomedicine platform has been developed, which is based on natural biocompatible biopolymers, capabale of targeting cancer cells with functional surface expression of CD44.
PMID: 28212584 [PubMed - as supplied by publisher]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
More News: Breast Carcinoma | Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Colon Cancer | Colorectal Cancer | Gastric (Stomach) Cancer | Nanotechnology | Ovarian Cancer | Ovaries